Addus Homecare (NASDAQ:ADUS) Stock Rating Lowered by ValuEngine

Addus Homecare (NASDAQ:ADUS) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, ValuEngine reports.

A number of other equities analysts have also weighed in on the company. BidaskClub raised Addus Homecare from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 14th. Oppenheimer set a $91.00 price target on Addus Homecare and gave the company a “buy” rating in a research note on Tuesday, September 17th. BMO Capital Markets set a $85.00 price target on Addus Homecare and gave the company a “hold” rating in a research note on Wednesday, August 7th. William Blair reissued an “outperform” rating on shares of Addus Homecare in a research note on Friday, August 9th. Finally, Sidoti set a $115.00 target price on Addus Homecare and gave the stock a “buy” rating in a research note on Wednesday, August 21st. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $88.29.

NASDAQ ADUS traded up $2.27 on Wednesday, reaching $81.56. 180,009 shares of the company were exchanged, compared to its average volume of 129,506. The business’s fifty day moving average price is $82.95 and its 200 day moving average price is $74.38. The stock has a market capitalization of $1.26 billion, a P/E ratio of 48.26, a price-to-earnings-growth ratio of 2.53 and a beta of -0.17. The company has a current ratio of 2.84, a quick ratio of 2.84 and a debt-to-equity ratio of 0.17. Addus Homecare has a fifty-two week low of $57.94 and a fifty-two week high of $92.91.

Addus Homecare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 5th. The company reported $0.47 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.47. The company had revenue of $149.69 million for the quarter, compared to analyst estimates of $146.66 million. Addus Homecare had a return on equity of 8.55% and a net margin of 3.31%. Equities research analysts forecast that Addus Homecare will post 2 earnings per share for the current year.

In related news, EVP Laurie Manning sold 990 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $83.21, for a total transaction of $82,377.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider W Bradley Bickham sold 15,000 shares of the stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $80.67, for a total value of $1,210,050.00. Following the transaction, the insider now directly owns 38,311 shares in the company, valued at approximately $3,090,548.37. The disclosure for this sale can be found here. 20.10% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. increased its holdings in Addus Homecare by 3.6% during the 2nd quarter. BlackRock Inc. now owns 1,551,759 shares of the company’s stock worth $116,305,000 after purchasing an additional 54,424 shares during the period. TimesSquare Capital Management LLC increased its holdings in Addus Homecare by 4.0% during the 2nd quarter. TimesSquare Capital Management LLC now owns 918,300 shares of the company’s stock worth $68,827,000 after purchasing an additional 35,570 shares during the period. Invesco Ltd. increased its holdings in Addus Homecare by 199.7% during the 2nd quarter. Invesco Ltd. now owns 330,362 shares of the company’s stock worth $24,760,000 after purchasing an additional 220,140 shares during the period. Royal Bank of Canada increased its holdings in Addus Homecare by 8.5% during the 2nd quarter. Royal Bank of Canada now owns 255,645 shares of the company’s stock worth $19,161,000 after purchasing an additional 20,096 shares during the period. Finally, Allianz Asset Management GmbH increased its holdings in Addus Homecare by 15.3% during the 2nd quarter. Allianz Asset Management GmbH now owns 235,279 shares of the company’s stock worth $17,634,000 after purchasing an additional 31,152 shares during the period. Institutional investors own 85.36% of the company’s stock.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

Recommended Story: What are no-load funds?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.